Chemoinformaics analysis of 9,14-Dihydroxyoctadecanoic acid
Molecular Weight | 316.482 | nRot | 16 |
Heavy Atom Molecular Weight | 280.194 | nRig | 7 |
Exact Molecular Weight | 316.261 | nRing | 0 |
Solubility: LogS | -3.475 | nHRing | 0 |
Solubility: LogP | 3.523 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 57.2725 |
nHD | 3 | BPOL | 36.9835 |
QED | 0.523 |
Synth | 1.323 |
Natural Product Likeliness | -0.32 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.258 |
MDCK | 0.0000279 |
BBB | 0.232 |
PPB | 0.951121 |
VDSS | 1.444 |
FU | 0.0505946 |
CYP1A2-inh | 0.986 |
CYP1A2-sub | 0.659 |
CYP2c19-inh | 0.92 |
CYP2c19-sub | 0.105 |
CYP2c9-inh | 0.574 |
CYP2c9-sub | 0.398 |
CYP2d6-inh | 0.069 |
CYP2d6-sub | 0.131 |
CYP3a4-inh | 0.064 |
CYP3a4-sub | 0.176 |
CL | 11.927 |
T12 | 0.794 |
hERG | 0.143 |
Ames | 0.006 |
ROA | 0.015 |
SkinSen | 0.666 |
Carcinogencity | 0.101 |
EI | 0.991 |
Respiratory | 0.094 |
NR-Aromatase | 0.019 |
Antiviral | Yes |
Prediction | 0.582333 |